Prescriber Perceptions around CRISPR in 2023
Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR. This research reflects the comparisons of awareness between 2019 and 2023 of nucleic acid-based therapies with a specific focus on CRISPR.
Our 2023 report includes responses from over 100 qualified US-based healthcare professionals (HCPs) familiar with the therapies considered in the research.
- Awareness of CRISPR and mRNA
- Optimism and concerns regarding the widespread use of CRISPR
- Comfort level recommending and administering CRISPR to patients
Get our key takeaways. Download the report today.